Tokenized stocks have grown to a $3.6 billion market across 4,555 assets, showing a split in growth trends: Avalanche leads in institutional capital with $131.2 million added recently, driven by large investors like Blackrock-backed Securitize, while Solana and Robinhood attract a surge in retail users, adding over 200,000 new holders combined. Despite Avalanche's institutional dominance, Solana leads in new tokenized-stock holders, highlighting different adoption paths. Decentralized exchanges processed $20.9 billion in tokenized-stock volume over the past month, with Uniswap capturing the largest share, signaling growing onchain trading activity and the emergence of tokenized stocks as a diverse ecosystem rather than a single market.
Tokenized stocks market dynamics show a split in growth trends. For readers following major cryptocurrencies on Pluang as of Sep 30, 2026 05:41 WIB, 36 of 50 major cryptocurrencies rose while 13 fell. Avalanche (AVAX) gained 10.65% to Rp205.933 with a typical hold time of 87 days and a buy order activity of 68%, contrasting with Balancer (BAL) which rose 11.14% to Rp16.297 and EOS (EOS.IO) up 8.13% to Rp12.649, both also held typically for 85-87 days.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...
